ETS1 is conventionally recognized as an oncogene in most of cancers [55,56], which is conflicted with the result of our study that illustrates significantly decreased ETS1 mRNA levels in BRCA tumor samples compared with adjacent normal samples (Figure 5F for details). This evidence concerns the gene ETS1 and cancer.